ZURICH/BERLIN, March 22 (Reuters) - The Swiss blue-chip SMI was seen opening 0.2 percent higher at 9,471 points on Friday, according to premarket indications by bank Julius Baer .
Here are some of the main factors that may affect Swiss stocks:
Credit Suisse Chief Executive Tidjane Thiam was awarded 12.65 million Swiss francs ($12.74 million) in total compensation in 2018, the group's annual report showed on Friday.
Swiss watchmakers are confident they can grow sales this year even in the face of a cooling Chinese economy, executives told Reuters at an industry fair on Thursday.
Shares in Alcon, the eye care business being spun-off by Novartis NOVN.S, are expected to start trading on April 9 on the Swiss market and the New York Stock Exchange, the Swiss pharmaceuticals company said on Friday.
Medical device maker Medacta Group SA on Friday announced a price range of 88 to 104 Swiss francs per share for its flotation and said that its stock would likely begin trading on the SIX Swiss exchange on April 4.
Annual general meeting
*Interroll Holding said it reached a full-year order intake of 592.6 million Swiss francs ($596.96 million).
*Schaffner Holding adjusted its outlook, saying sales were now expected to come in below last year's level.
*Adval Tech Holding said it reached a full-year EBITDA of 20.7 million francs.
* Plazza Immobilien FY Profit Up 39 Pct To CHF 23.6 Million
* Mikron Holding said it was informed that Veraison Sicav had sold all shares in Mikron Holding
No major economic data scheduled.
$1 = 0.9927 Swiss francs Reporting by Zurich newsroom and Berlin Speed Desk